Dr. Centor discusses the risks and benefits of using SGLT2 inhibitors to treat patients with type 2 diabetes with Dr. Katherine Tuttle, an endocrinologist and nephrologist at Washington State University.

SGLT2 Inhibitors: The Good, the Bad, and the Ugly

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.

Medicine

Science & Medicine

Health & Fitness

Dr. Centor discusses the adverse events associated with checkpoint inhibitors with Drs. Reaford Blackburn Jr. and Brian C. Westbrook.

Checkpoint Inhibitors: What Generalists Need to Know

Dr. Centor discusses how to go beyond statistical significance testing when interpreting study findings with Dr. David Savitz.

Improving Research Reports: Avoiding p-Values

Dr. Centor discusses the real-world complications of lung cancer screening with Drs. Katharine A. Rendle and Anil Vachani.

Real World Complications of Lung Cancer Screening

Dr. Centor discusses the association between gabapentinoids and chronic obstructive pulmonary disease with Mr. Rahman and Dr. Renoux.

Gabapentinoids and COPD: Not a Good Mix?

Dr. Centor discusses encouraging patients to receive influenza vaccination with Drs. Mark Tenforde and Fatimah Dawood.

SGLT2 Inhibitors: The Good, the Bad, and the Ugly

Download our free app to listen on your phone